These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 2579857

  • 1. Newborn response to cationic amphiphilic drugs.
    Kacew S, Reasor MJ.
    Fed Proc; 1985 Apr; 44(7):2323-7. PubMed ID: 2579857
    [Abstract] [Full Text] [Related]

  • 2. Gentamicin or chlorphentermine induction of phospholipidosis in the developing organism: role of tissue and species in manifestation of toxicity.
    Kacew S.
    J Pharmacol Exp Ther; 1985 Jan; 232(1):239-43. PubMed ID: 3965695
    [Abstract] [Full Text] [Related]

  • 3. Modification by phenobarbital of chlorphentermine-induced changes in lung morphology and drug-metabolizing enzymes in newborn rats.
    Kacew S, Parulekar MR, Narbaitz R, Ruddick JA, Villeneuve DC.
    J Toxicol Environ Health; 1981 Jan; 8(5-6):873-84. PubMed ID: 7338948
    [Abstract] [Full Text] [Related]

  • 4. Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital.
    Reasor MJ, Davis ME.
    Drug Metab Dispos; 1985 Jan; 13(2):192-6. PubMed ID: 2859167
    [Abstract] [Full Text] [Related]

  • 5. Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs.
    Reasor MJ.
    Fed Proc; 1984 Aug; 43(11):2578-81. PubMed ID: 6745447
    [Abstract] [Full Text] [Related]

  • 6. Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine.
    Kacew S.
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):469-76. PubMed ID: 3424375
    [Abstract] [Full Text] [Related]

  • 7. Role of age in amphiphilic drug-induced pulmonary morphological and metabolic responses.
    Kacew S.
    Fed Proc; 1984 Aug; 43(11):2592-6. PubMed ID: 6146538
    [Abstract] [Full Text] [Related]

  • 8. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro.
    Heyneman CA, Reasor MJ.
    J Pharmacol Exp Ther; 1986 Jan; 236(1):60-4. PubMed ID: 3941401
    [Abstract] [Full Text] [Related]

  • 9. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels.
    Heyneman CA, Reasor MJ.
    J Pharmacol Exp Ther; 1986 Jan; 236(1):55-9. PubMed ID: 3941400
    [Abstract] [Full Text] [Related]

  • 10. Alterations in newborn and adult rat lung morphology and phospholipid levels after chlorcyclizine or chlorphentermine treatment.
    Kacew S.
    Toxicol Appl Pharmacol; 1982 Aug; 65(1):100-8. PubMed ID: 6128805
    [No Abstract] [Full Text] [Related]

  • 11. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
    Coulombe PA, Bendayan M.
    J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
    [Abstract] [Full Text] [Related]

  • 12. Neonatal toxicity in rats following in utero exposure to chlorphentermine or phentermine.
    Thoma-Laurie D, Walker ER, Reasor MJ.
    Toxicology; 1982 Feb; 24(1):85-94. PubMed ID: 7135406
    [Abstract] [Full Text] [Related]

  • 13. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM, Beard TL, Kacew S, Reasor MJ.
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [Abstract] [Full Text] [Related]

  • 14. Effect of drug-induced phospholipidosis on pulmonary disposition of pneumophilic drugs.
    Ohmiya Y, Angevine LS, Mehendale HM.
    Drug Metab Dispos; 1983 Feb; 11(1):25-30. PubMed ID: 6132791
    [No Abstract] [Full Text] [Related]

  • 15. Morphological and functional changes in mouse splenic lymphocytes following in vivo and in vitro exposure to chlorphentermine.
    Sauers LJ, Wierda D, Walker ER, Reasor MJ.
    J Immunopharmacol; 1986 Feb; 8(4):611-31. PubMed ID: 3027187
    [Abstract] [Full Text] [Related]

  • 16. Modification by hyperoxia of chlorphentermine- or phentermine- induced effects on newborn rat lung morphology and metabolism.
    Kacew S, Narbaitz R.
    Drug Chem Toxicol; 1981 Feb; 4(2):123-32. PubMed ID: 6274604
    [Abstract] [Full Text] [Related]

  • 17. Chlorphentermine-induced alterations in pulmonary phospholipid content in rats.
    Kacew S, Reasor MJ.
    Biochem Pharmacol; 1983 Sep 15; 32(18):2683-8. PubMed ID: 6626239
    [Abstract] [Full Text] [Related]

  • 18. Drug-induced phospholipidosis. II. Alterations in the phospholipid pattern of organs from mice, rats and guinea-pigs after chronic treatment with chlorphentermine.
    Seiler KU, Wassermann O.
    Naunyn Schmiedebergs Arch Pharmacol; 1975 Sep 15; 288(2-3):261-8. PubMed ID: 1161047
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhaled cationic amphiphilic drug-induced pulmonary phospholipidosis in rats and dogs: time-course and dose-response of biomarkers of exposure and effect.
    Pauluhn J.
    Toxicology; 2005 Feb 01; 207(1):59-72. PubMed ID: 15590122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.